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Abstract: AIMS The Academic Research Consortium for High Bleeding Risk (ARC-HBR) defined consensus-
based criteria for patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention
(PCI). We aimed to validate the ARC-HBR criteria for the bleeding outcomes using a large cohort of
patients undergoing PCI. METHODS AND RESULTS Between 2009 and 2016, patients undergoing PCI
were prospectively included in the Bern PCI Registry. Patients were considered to be at HBR if at
least one major criterion or two minor criteria were met. The primary endpoint was Bleeding Academic
Research Consortium (BARC) 3 or 5 bleeding at one year; ischaemic outcomes were assessed using the
device-oriented composite endpoints (DOCE) of cardiac death, target vessel myocardial infarction, and
target lesion revascularisation. Among 12,121 patients, those at HBR (n=4,781, 39.4%) had an increased
risk of BARC 3 or 5 bleeding (6.4% vs 1.9%; p<0.001) and DOCE (12.5% vs 6.1%; p<0.001) compared
with those without HBR. The degree of risk and prognostic value were related to the risk factors compos-
ing the criteria. The ARC-HBR criteria had higher sensitivity than the PRECISE-DAPT score and the
PARIS bleeding risk score (63.8%, 53.1%, 31.9%), but lower specificity (62.7%, 71.3%, 86.5%) for BARC
3 or 5 bleeding. CONCLUSIONS Patients at HBR defined by the ARC-HBR criteria had a higher risk of
BARC 3 or 5 bleeding as well as DOCE. The bleeding risk was related to its individual components. The
ARC-HBR criteria were more sensitive for identifying patients with future bleedings than other contem-
porary risk scores at the cost of specificity. ClinicalTrials.gov Identifier: NCT02241291 Visual summary.
According to the ARC-HBR criteria, 40% of patients undergoing PCI were at HBR. Compared with
patients without HBR, those at HBR had an increased risk of BARC 3 or 5 bleeding (6.4% vs 1.9%,
p<0.001). There was a gradual risk increase for BARC 3 or 5 bleeding and DOCE as a function of the
ARC-HBR score. BARC: Bleeding Academic Research Consortium; DOCE: device-oriented composite
endpoints; HBR: high bleeding risk.
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